Adia Nutrition (ADIA) Capital Expenditures (2026)
Adia Nutrition's (ADIA) quarterly Capital Expenditures came in at $5494.0 in Q1 2026.
Powered by 
Analysis
Adia Nutrition (ADIA) Capital Expenditures (2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Capital Expenditures for 1 consecutive years, with $5494.0 the latest figure, recorded in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | 3.57 Mn |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | 648,000.00 |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | 5.44 Mn |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | -7.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 472,000.00 |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | 392,000.00 |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | 2.41 Mn |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | 555,000.00 |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 1.73 Mn |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |